Acute pulmonary embolism with coexisting right heart thrombi in transit-surgical treatment of 20 consecutive patients.

Acute pulmonary embolism Free-floating right heart thrombus Mobile thrombus Patent foramen ovale Pulmonary embolectomy Right heart thrombus Thrombus in transit

Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
03 04 2023
Historique:
received: 12 09 2022
revised: 12 01 2023
accepted: 19 01 2023
medline: 28 4 2023
pubmed: 21 1 2023
entrez: 20 1 2023
Statut: ppublish

Résumé

The presence of right heart thrombi in transit (RHTiT) in the setting of acute pulmonary embolism (PE) is associated with high mortality. The optimal management in such cases is inconclusive. We present the results of surgical treatment of 20 consecutive patients diagnosed with high- or intermediate-high-risk PE with coexisting RHTiT. A retrospective analysis was performed of all consecutive patients undergoing surgical treatment in the Medicover Hospital between 2013 and 2021 for acute PE with coexisting thrombi in-transit in right heart cavities. The diagnosis was based on echocardiography, computed tomography pulmonary angiography and laboratory tests. Eligibility criteria for surgical treatment were acute PE with RHTiT, right ventricular overload on imaging studies and significantly elevated levels of cardiac troponin and NTproBNP. All patients were operated on with extracorporeal circulation using deep hypothermia and total circulatory arrest. The primary end point was hospital all-cause mortality; secondary end points were perioperative complications and long-term mortality. The analysis included 20 patients. There was no in-hospital death. Nearly one-third of patients required temporal hemofiltration for postoperative renal failure, but this did not involve the need for dialysis at discharge. No neurological complications occurred in any patient. The mean follow-up was 46 months (range 13-98). There was 1 death in the long-term follow-up, not related to PE. Surgical treatment of patients with acute PE and coexisting RHTiT can provide favourable results.

Identifiants

pubmed: 36661312
pii: 6994185
doi: 10.1093/ejcts/ezad022
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Dariusz Zieliński (D)

Cardiac Surgery Department, Medicover Hospital, Warsaw, Poland.
Faculty of Medicine, Lazarski University, Warsaw, Poland.

Marcin Zygier (M)

Cardiac Surgery Department, Medicover Hospital, Warsaw, Poland.
Faculty of Medicine, Lazarski University, Warsaw, Poland.

Wojciech Dyk (W)

Cardiac Surgery Department, Medicover Hospital, Warsaw, Poland.
Faculty of Medicine, Lazarski University, Warsaw, Poland.

Ryszard Wojdyga (R)

Cardiac Surgery Department, Medicover Hospital, Warsaw, Poland.
Faculty of Medicine, Lazarski University, Warsaw, Poland.

Krzysztof Wróbel (K)

Cardiac Surgery Department, Medicover Hospital, Warsaw, Poland.
Faculty of Medicine, Lazarski University, Warsaw, Poland.

Ewelina Pirsztuk (E)

Department of Anaesthesiology and Intensive Care, Medicover Hospital, Warsaw, Poland.

Katarzyna Szostakiewicz (K)

Department of Anaesthesiology and Intensive Care, Medicover Hospital, Warsaw, Poland.

Piotr Szatkowski (P)

Department of Anaesthesiology and Intensive Care, Medicover Hospital, Warsaw, Poland.
Department of Anaesthesiology, National Institute of Cardiology, Warsaw, Poland.

Szymon Darocha (S)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre, Otwock, Poland.

Marcin Kurzyna (M)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre, Otwock, Poland.

Michał Ciurzyński (M)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.

Michał Machowski (M)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.

Piotr Pruszczyk (P)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.

Adam Torbicki (A)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre, Otwock, Poland.

Andrzej Biederman (A)

Cardiac Surgery Department, Medicover Hospital, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH